Breast cancer molecular atlas identified novel forms of the disease

Researchers at Vanderbilt-Ingram Cancer Center generated a large transcriptomic map of breast cancer to identify novel forms of the disease. EurekAlert! reported on 3 November 2026 that the study was published in the journal Cell Reports Medicine. The molecular map establishes a foundation for selecting personalized treatments guided by the molecular characteristics of a tumor rather than standard pathology alone. [1]

The new molecular atlas visualizes breast cancer data as a traditional map resembling an archipelago. EurekAlert! reported that distinct breast cancer subtypes populate different islands on the map. Subtypes grouped together on these islands share common molecular features, treatment responses, and clinical outcomes. [1]

As FTMQ Health reported earlier, precision oncology tools may help identify patients who can safely reduce systemic therapies and avoid severe side effects. Systemic treatments can cause severe side effects while sometimes offering limited clinical benefit to patients. Local therapy is most effective in early-stage breast cancer, whereas systemic treatment is generally used for advanced disease. [5]

Efforts to improve breast cancer care also include clinical trials testing shorter treatment schedules. As FTMQ Health reported earlier, a government-funded clinical trial in the United Kingdom is evaluating whether a condensed five-day radiotherapy schedule can safely replace three weeks of standard treatment. More than 1,000 patients have enrolled in that study across 39 UK hospitals. [4]